REG-BARCLAYS PLC Form 8.3 - WILLIS TOWERS WATSON PLC
23/03/2021 12:25
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20210323:nBw9bd5DLa&default-theme=true
Form 8.3 - WILLIS TOWERS WATSON PLC
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER
RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE
1. KEY INFORMATION
Name of person dealing (Note 1) Barclays PLC.
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 22 March 2021
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant
security dealt in (Note 3)
Class of relevant security: ORD
Long Short
Number (%) Number (%)
(1) Relevant securities
1,804,555 1.40% 184,156 0.14%
(2) Derivatives (other than options):
102,935 0.08% 7,066 0.01%
(3) Options and agreements to
purchase/sell: 6,100 0.00% 6,100 0.00%
TOTAL:
1,913,590 1.48% 197,322 0.15%
(b) Interests and short positions in relevant securities of the company, other
than the class dealt in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit
Purchase 1 221.4800 USD
Purchase 5 220.1000 USD
Purchase 50 221.3200 USD
Purchase 60 220.5100 USD
Purchase 70 220.9300 USD
Purchase 100 221.0800 USD
Purchase 100 220.6400 USD
Purchase 102 221.1845 USD
Purchase 200 220.8750 USD
Purchase 253 220.9212 USD
Purchase 290 220.6220 USD
Purchase 294 221.1658 USD
Purchase 300 220.9800 USD
Purchase 335 220.9880 USD
Purchase 400 221.0225 USD
Purchase 500 221.1490 USD
Purchase 600 221.1562 USD
Purchase 700 220.8757 USD
Purchase 700 220.9907 USD
Purchase 734 220.7391 USD
Purchase 757 221.1200 USD
Purchase 900 221.0255 USD
Purchase 1,045 220.8565 USD
Purchase 1,244 221.2708 USD
Purchase 1,464 220.7890 USD
Purchase 3,137 220.8000 USD
Purchase 3,265 220.8172 USD
Purchase 3,786 220.6028 USD
Purchase 4,325 220.7105 USD
Purchase 5,449 220.7370 USD
Purchase 5,556 220.5726 USD
Purchase 6,132 220.0496 USD
Purchase 9,703 220.9688 USD
Purchase 14,056 221.0305 USD
Purchase 20,014 220.7996 USD
Sale 9 221.6800 USD
Sale 11 221.6700 USD
Sale 20 220.9100 USD
Sale 35 220.9288 USD
Sale 41 220.0200 USD
Sale 56 220.7600 USD
Sale 57 221.1200 USD
Sale 60 220.5100 USD
Sale 70 220.9300 USD
Sale 100 220.7850 USD
Sale 100 220.9450 USD
Sale 100 220.0300 USD
Sale 100 220.3200 USD
Sale 128 220.0000 USD
Sale 140 220.6014 USD
Sale 162 220.3729 USD
Sale 165 220.7864 USD
Sale 200 221.0025 USD
Sale 200 220.5750 USD
Sale 293 220.5431 USD
Sale 294 221.1658 USD
Sale 300 221.0600 USD
Sale 314 220.1592 USD
Sale 400 220.9562 USD
Sale 760 220.8725 USD
Sale 946 220.1760 USD
Sale 1,145 220.8760 USD
Sale 1,260 220.3911 USD
Sale 1,685 220.4105 USD
Sale 1,806 220.8003 USD
Sale 2,356 220.8290 USD
Sale 3,031 220.8000 USD
Sale 3,205 220.8653 USD
Sale 5,275 220.7349 USD
Sale 5,484 220.6346 USD
Sale 7,762 220.9789 USD
Sale 7,789 220.2871 USD
Sale 20,000 221.0466 USD
Sale 20,851 220.8076 USD
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5)
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)
e.g. call option
(ii) Exercising
Product name, Number of securities Exercise price per unit (Note 5)
e.g. call option
(d) Other dealings (including transactions in respect of new securities) (Note
4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which
any derivative referred to on this form is referenced. If none, this should be
stated.
None
Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure: 23 Mar 2021
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or
Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
Product name Written or Number of Exercise Type Expiry
purchased relevant securities price date
to which the option
or derivative
relates
Put Options Purchased -100 220.0000 American Jul 16, 2021
Call Options Purchased 100 240.0000 American Jul 16, 2021
Call Options Purchased 6,000 220.0000 American Jul 16, 2021
Put Options Purchased -6,000 200.0000 American Jul 16, 2021
Notes
1. Where there are open option positions or open derivative positions (except
for CFDs), full details should be given. Full details of any existing
agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in
doubt, consult the Panel.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20210323005678/en/
(https://www.businesswire.com/news/home/20210323005678/en/)
BARCLAYS PLC
Copyright Business Wire 2021Recent news on Barclays
See all newsREG - Barclays PLC British Land Co PLC - Form 8.3 BRITISH LAND COMPANY PLC, THE
AnnouncementREG - Barclays PLC Spire Healthcare Grp - Form 8.3 SPIRE HEALTHCARE GROUP PLC
AnnouncementREG - Barclays PLC NCC Group PLC - Form 8.3 NCC GROUP PLC
AnnouncementREG - Barclays PLC Life Science REIT - Form 8.3 LIFE SCIENCE REIT PLC
AnnouncementREG - Barclays PLC IQE PLC - Form 8.3 IQE PLC
Announcement